PROGRAM

TCT 2019 will feature a host of sponsored satellite programs offering attendees comprehensive insights into important interventional topics and issues facing interventional specialists. 

Sponsored sessions include breakfast programs, lunchtime Presentation Theater programs, and evening programming. 

Satellite Programs

Ability to Treat Diabetic Patients With a Novel Combined DES and DCB in a Single Platform

Presentation Theater Program

09/28/2019 13:00:00 09/28/2019 14:00:00 Ability to Treat Diabetic Patients With a Novel Combined DES and DCB in a Single Platform TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Presentation Theater Program

Saturday, September 28, 2019
Program: 1:00 pm-2:00 pm
The Moscone Center, Presentation Theater 2, Hall D, Exhibition Level, Moscone South

Ability to Treat Diabetic Patients With a Novel Combined DES and DCB in a Single Platform

Ability to Treat Diabetic Patients With a Novel Combined DES and DCB in a Single Platform

Sponsored by Concept Medical, Inc.

Chairs  

Antonio Colombo

Columbus Hospital/Maria Cecilia Hospital

Milan, Italy

 

Roxana Mehran

Mount Sinai School of Medicine

New York,

 

Marie-Claude Morice

Institut Cardiovasculaire Paris Sud

Paris, France

Faculty  

Sameer Dani

Apollo CVHF Heart Institute

Ahmedabad, India

 

Prathap Kumar

Meditrina Hospital

Trivendrum, India

 

Azeem Latib

Montefiore Medical Center / Albert Einstein College of Medicine

New York,

 

Ashok Seth

Fortis Escorts Heart Institute

Delhi, India

 

Paolo Vicinelli

ASST Ovest Milanese

Milan, Italy

 

Alfonso Ielasi

S. Ambrogio Clinical Institute

Milan, Italy

 

Luca Testa

IRCCS Pol. S. Donato

Milan, Italy

Agenda

1:00 pm

Why do we need a dedicated DES for diabetes? Introducing the Abluminus concept

Roxana Mehran

1:08 pm

Multicenter real world data from global registries

Luca Testa

1:16 pm

Case 1: Step-by-Step treatment strategy of complex diabetic patient with Abluminus DES

Sameer Dani

1:22 pm

Case 2: Abluminus in CHIP cases and outcomes

Paolo Vicinelli

1:28 pm

Case 3: Diabetic patient – Multivessel disease with LM - 2 years IVUS follow-up

Prathap Kumar

1:34 pm

The ABILITY DIABETES GLOBAL Imaging Study (randomised control trial comparing Abluminus DES vs. Xience)

Azeem Latib

1:42 pm

The ABILITY DIABETES GLOBAL Trial: The largest randomised control trial with coronary stents for the diabetic population

Antonio Colombo

1:50 pm

Panel Discussion and audience interaction

Discussants : Ashok Seth, Paolo Vicinelli, Alfonso Ielasi

2:00 pm

Adjourn